Globus Medical Cash Flow Conversion Efficiency

Latest as of June 2026: 0.086x

Globus Medical cash flow conversion efficiency. Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.086x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($412.11 Million) by net assets ($4.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Globus Medical (2010–2025)

Cash flow conversion efficiency of Globus Medical from 2010 to 2025. This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Globus Medical (GMED) share price today for real-time trading data and today's change.

Globus Medical Cash Flow Conversion Ratio Explained

Globus Medical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Globus Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency. Also see GMED market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Baloise Holding AG
SW:BALN
0.211x
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
-0.079x
Voya Financial Inc
NYSE:VOYA
-0.418x
Sirius XM Holding Inc
NASDAQ:SIRI
0.023x
thyssenkrupp AG
XETRA:TKA
-0.120x
The Federal Bank Limited
NSE:FEDERALBNK
-0.058x
Banca Transilvania S.A.
RO:TLV
0.028x
Li Auto Inc
NASDAQ:LI
0.000x

Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2025)

The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2025. Review Globus Medical free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $4.57 Billion $753.45 Million 0.165x +32.19%
2024-12-31 $4.18 Billion $520.64 Million 0.125x +104.63%
2023-12-31 $4.00 Billion $243.50 Million 0.061x -36.99%
2022-12-31 $1.85 Billion $178.47 Million 0.097x -39.07%
2021-12-31 $1.74 Billion $276.27 Million 0.159x +20.21%
2020-12-31 $1.51 Billion $198.79 Million 0.132x +7.63%
2019-12-31 $1.40 Billion $171.97 Million 0.123x -19.97%
2018-12-31 $1.19 Billion $181.64 Million 0.153x -7.05%
2017-12-31 $967.78 Million $159.53 Million 0.165x -20.20%
2016-12-31 $832.08 Million $171.89 Million 0.207x +21.17%
2015-12-31 $715.32 Million $121.96 Million 0.170x +26.07%
2014-12-31 $585.45 Million $79.17 Million 0.135x -31.66%
2013-12-31 $472.36 Million $93.47 Million 0.198x -0.05%
2012-12-31 $386.50 Million $76.52 Million 0.198x -26.81%
2011-12-31 $282.48 Million $76.41 Million 0.271x -13.41%
2010-12-31 $228.19 Million $71.29 Million 0.312x --

About Globus Medical

NYSE:GMED USA Medical Devices
Market Cap
$9.00 Billion
Market Cap Rank
#2344 Global
#877 in USA
Share Price
$79.46
Change (1 day)
+1.81%
52-Week Range
$61.51 - $96.82
All Time High
$96.82
About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more